IL141920A0 - Process for the preparation of alkyl mercapto methyl ergoline derivatives - Google Patents

Process for the preparation of alkyl mercapto methyl ergoline derivatives

Info

Publication number
IL141920A0
IL141920A0 IL141920??A IL14192099A IL141920A0 IL 141920 A0 IL141920 A0 IL 141920A0 IL 14192099 A IL14192099 A IL 14192099A IL 141920 A0 IL141920 A0 IL 141920A0
Authority
IL
Israel
Prior art keywords
preparation
mercapto methyl
alkyl mercapto
ergoline derivatives
methyl ergoline
Prior art date
Application number
IL141920??A
Other languages
English (en)
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Publication of IL141920A0 publication Critical patent/IL141920A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL141920??A 1999-01-27 1999-12-31 Process for the preparation of alkyl mercapto methyl ergoline derivatives IL141920A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000146A IT1307934B1 (it) 1999-01-27 1999-01-27 Processo per la preparazione di derivati alchimercaptometilergolinici.
PCT/EP1999/010493 WO2000044748A1 (en) 1999-01-27 1999-12-31 Process for the preparation of alkyl mercapto methyl ergoline derivatives

Publications (1)

Publication Number Publication Date
IL141920A0 true IL141920A0 (en) 2002-03-10

Family

ID=11381633

Family Applications (2)

Application Number Title Priority Date Filing Date
IL141920??A IL141920A0 (en) 1999-01-27 1999-12-31 Process for the preparation of alkyl mercapto methyl ergoline derivatives
IL141920A IL141920A (en) 1999-01-27 2001-03-08 Process for the preparation of derivatives of alkyl mercapto methyl ergoline and a number of new intermediates obtained during it

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL141920A IL141920A (en) 1999-01-27 2001-03-08 Process for the preparation of derivatives of alkyl mercapto methyl ergoline and a number of new intermediates obtained during it

Country Status (10)

Country Link
US (1) US6395901B1 (it)
EP (1) EP1147106B1 (it)
JP (1) JP4593789B2 (it)
AT (1) ATE386032T1 (it)
CZ (1) CZ300684B6 (it)
DE (1) DE69938153D1 (it)
IL (2) IL141920A0 (it)
IT (1) IT1307934B1 (it)
SK (1) SK286599B6 (it)
WO (1) WO2000044748A1 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10053397A1 (de) 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
WO2003078432A2 (en) * 2002-03-15 2003-09-25 Antibioticos S.P.A. Process for the synthesis of pergolide
ITMI20021755A1 (it) 2002-08-02 2002-11-01 Poli Ind Chimica Spa Processo e nuovi intermedi per la preparazione di steroidi ad attivita' progestinica.
GB0409785D0 (en) * 2004-04-30 2004-06-09 Resolution Chemicals Ltd Preparation of cabergoline
US7339060B2 (en) 2005-03-23 2008-03-04 Resolution Chemicals, Ltd. Preparation of cabergoline
GB0505965D0 (en) * 2005-03-23 2005-04-27 Resolution Chemicals Ltd Preparation of cabergoline
US20070197576A1 (en) * 2006-02-08 2007-08-23 Resolution Chemicals Limited Production of Cabergoline and Novel Polymorphic Form Thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0240647B2 (ja) * 1978-02-08 1990-09-12 Lilly Co Eli Purorakuchinbunpyokuseizai
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
JPH0240044B2 (ja) * 1978-02-08 1990-09-10 Lilly Co Eli Paakinsonshokogunchiryozai
US4246265A (en) * 1979-10-01 1981-01-20 Eli Lilly And Company 6-n-Propyl-8α-methoxymethyl or methylmercaptomethylergolines and related compounds
US4782152A (en) * 1985-08-16 1988-11-01 Eli Lilly And Company Decyanation of pergolide intermediate
US5463060A (en) * 1992-05-21 1995-10-31 Eli Lilly And Company One-pot process

Also Published As

Publication number Publication date
JP4593789B2 (ja) 2010-12-08
SK10402001A3 (sk) 2002-04-04
IL141920A (en) 2008-11-26
CZ20012640A3 (cs) 2002-02-13
ITMI990146A1 (it) 2000-07-27
EP1147106A1 (en) 2001-10-24
EP1147106B1 (en) 2008-02-13
JP2002535403A (ja) 2002-10-22
DE69938153D1 (de) 2008-03-27
US6395901B1 (en) 2002-05-28
WO2000044748A1 (en) 2000-08-03
IT1307934B1 (it) 2001-11-29
CZ300684B6 (cs) 2009-07-15
SK286599B6 (sk) 2009-02-05
ATE386032T1 (de) 2008-03-15

Similar Documents

Publication Publication Date Title
GR3020483T3 (en) Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use
HU9702482D0 (en) New intermediates for producing gaba and l-glutaminic acid analogues
AU6782090A (en) 2-substituted phenyl-2-oxazoline or thiazoline derivatives, process for producing the same and insectides and acaricides containing the same
AU4218093A (en) New peptides derived from trifluoromethyl ketones, process for their preparation and the pharmaceutical compositions which contain them
HK1023064A1 (en) Method of inhibiting bacterial or fungal growth using a complexing agent
PT75357A (en) Process for preparation of 1-, and 1,1-disubstituted-2-carbamidoyl-1-carbadethiapen-2-em-3-carboxylic acids
PH25859A (en) Composition for treatment of ischemic disorder
PL373460A1 (en) Pleuromutilin derivatives as antimicrobbials
IL141920A0 (en) Process for the preparation of alkyl mercapto methyl ergoline derivatives
ES8607260A1 (es) Procedimiento para la preparavion de 4h-3, l-benzoxazin-4-onas y compuestos relacionados
TW340115B (en) Triazine derivatives and pharmaceutical composition for hepatitis the invention relates to triazine derivatives and pharmaceutical composition for hepatitis
HUT47211A (en) Insecticide, acaricide and nematocide composition containing cyclopropane-carboxylic acid esters as active component, and process for producing the active components
GR3023107T3 (en) New 19-nor 11-beta-phenoxysulfonamide or 11-beta-phenoxyalkylsulfonylurea steriod derivatives, a process and intermediates for their production and their use as medicaments and pharmaceuticals containing them.
MY132263A (en) Pyridazinone derivatives and processes for preparing the same
HUT57694A (en) Process for producing new beta-diketones and pharmaceutical compositions comprising same
WO1993025568A3 (en) Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use
CA2337669A1 (en) Process for the preparation of alkyl mercapto methyl ergoline derivatives
MXPA94001822A (es) Derivados de acido aciloxihexanoico.
WO1993004059A1 (en) 4-acylaminoimidazole derivative
HUT72591A (en) Piperazine derivatives for producing alkyl-trazodon derivatives and process for producing them
DE3371787D1 (en) 17-alpha-pregn-4-ene-3-oxo-21-carboxylic acid esters, process for the preparation thereof, and use thereof as medicinal agents
TW328083B (en) New derivatives of β-methoxy acrylic acid, their preparation process and their use as pesticides
ES8305377A1 (es) Un procedimiento para la preparacion de un derivado de nitrosourea.
ES2019551A6 (es) Procedimiento para la obtencion de derivados del acido 6-fluor-1, 4-dihidro-4-oxo-7-piperacinil-3-quinlincarboxilico.
MX9604924A (es) 2,3-dihidroxipropil-2-(1-oxoalquil)amino-2-desoxiglucopiranosidos, un procedimiento para su preparacion y su uso.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed